An update from Pfizer ( ($PFE) ) is now available. On November 13, 2025, Pfizer completed its acquisition of Metsera, Inc., a Delaware-based ...

Pfizer (PFE) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the future ...

NYSE:PFE Earnings and Revenue History November 11th 2025 How Do Unusual Items Influence Profit? To properly understand Pfizer's profit results, we need to consider the US$7.0b exp ...

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer has recently reported solid ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

Jon Smith explains why investors can look across the pond for stocks with attractive dividend forecasts and shares a specific example. The post A 7.5%+ yield? This S&P 500 stock has a juicy dividend ...

Dow Jones Top Company Headlines at 3 AM ET: Pfizer Preps Improved Offer in Metsera Bidding War | OpenAI ... Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at ...

Dow Jones Top Company Headlines at 1 AM ET: OpenAI Isn't Yet Working Toward an IPO, CFO Says | Pfizer ... Sarah Friar says the AI giant could reach break-even quickly and would like government ...

Nov 5 (Reuters) - Pfizer (PFE.N) plans to sweeten its bid for Metsera (MTSR.O), a person familiar with the matter told ...

A Delaware judge denied Pfizer's attempt to halt Metsera from accepting Novo Nordisk's $10 billion offer. Although Novo faces antitrust challenges, both companies are fiercely bidding for Metsera in a ...

Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted ...

Pfizer’s Q3 2025 earnings fell despite beating estimates. Weak growth and a stagnant outlook keep PFE stock a Hold.